Latest News
ODYSSEY confirms dolutegravir-based treatment is best for children living with HIV
New extended follow-up results from the global ODYSSEY clinical trial confirm that dolutegravir-based regimens are superior to other antiretroviral treatments for children living with HIV.
'25 at 25': Optimising treatments for people with cancer
As part of our 25th anniversary celebrations, we explore our trials that aim to improve quality of life by optimising treatments for people with cancer.